Single-Use Technology for Containment During ADC Handling
17:37
CMC Considerations for Commercial-Ready ADC Manufacturing Processes to Enable Accelerated Timelines
56:17
Application of DOE Design of Experiments to Antibody Drug Conjugates ADC Process Development
47:07
ADC and Highly Potent Substance Containment - A Full Life Cycle Safety Innovation
11:49
How do monoclonal antibodies work? Rituximab, infliximab, adalimumab and others
30:00
How Has Single-Use Increased Access to Biomanufacturing Solutions for Both CDMOs and End-Users?
27:03
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
30:15
[Webinar] Manufacturing concepts for antibody-drug conjugates | Webinar
4:33